IP vs TXG
International Paper (IP) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. TXG currently screens at market cap $4.08B.
Not investment advice. Open the IP and TXG stock pages for the full models.
Not investment advice.